Warning: The NCBI web site requires JavaScript to function. more...
B cells in autoimmunity.
Dörner T, Jacobi AM, Lipsky PE.
Arthritis Res Ther. 2009;11(5):247. Epub 2009 Oct 14. Review.
Related citations
Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
Dörner T.
J Rheumatol Suppl. 2006 May;77:3-11. Review.
Recent progress in the understanding of B-cell functions in autoimmunity.
Porakishvili N, Mageed R, Jamin C, Pers JO, Kulikova N, Renaudineau Y, Lydyard PM, Youinou P.
Scand J Immunol. 2001 Jul-Aug;54(1-2):30-8. Review.
Control of apoptosis in autoimmunity.
Maniati E, Potter P, Rogers NJ, Morley BJ.
J Pathol. 2008 Jan;214(2):190-8. Review.
B-lymphocyte contributions to human autoimmune disease.
Yanaba K, Bouaziz JD, Matsushita T, Magro CM, St Clair EW, Tedder TF.
Immunol Rev. 2008 Jun;223:284-99. Review.
Infections, B cell receptor activation and autoimmunity: different check-point impairments lead to autoimmunity, clonal B cell expansion and fibrosis in different immunological settings.
Ferraccioli G, Tolusso B.
Autoimmun Rev. 2007 Dec;7(2):109-13. Epub 2007 Mar 26. Review.
B cell conducts the lymphocyte orchestra.
Youinou P.
J Autoimmun. 2007 Mar-May;28(2-3):143-51. Epub 2007 Mar 23. Review.
Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
Salomon B, Bluestone JA.
Annu Rev Immunol. 2001;19:225-52. Review.
Autoimmunity, polyclonal B-cell activation and infection.
Granholm NA, Cavallo T.
Lupus. 1992 Feb;1(2):63-74. Review.
Activation of self-reactive B cells and autoimmune diseases.
Burrows PD, Suematsu S, Watanabe T.
Rev Immunogenet. 2000;2(1):38-51. Review.
Regulatory B cells as inhibitors of immune responses and inflammation.
Bouaziz JD, Yanaba K, Tedder TF.
Immunol Rev. 2008 Aug;224:201-14. Review.
Pathogenic roles of B cells in human autoimmunity; insights from the clinic.
Martin F, Chan AC.
Immunity. 2004 May;20(5):517-27. Review.
Mature B cells preferentially lose tolerance in the chronic graft-versus-host disease model of systemic lupus erythematosus.
Choudhury A, Cohen PL, Eisenberg RA.
J Immunol. 2007 Oct 15;179(8):5564-70.
B-cell targeting: a novel approach to immune intervention today and tomorrow.
Dörner T, Lipsky PE.
Expert Opin Biol Ther. 2007 Sep;7(9):1287-99. Review.
B-lymphocyte effector functions in health and disease.
DiLillo DJ, Horikawa M, Tedder TF.
Immunol Res. 2011 Apr;49(1-3):281-92. Review.
Effector and regulatory B cells: modulators of CD4(+) T cell immunity.
Lund FE, Randall TD.
Nat Rev Immunol. 2010 Apr;10(4):236-47. Epub 2010 Mar 12. Review.
Sites and stages of autoreactive B cell activation and regulation.
Shlomchik MJ.
Immunity. 2008 Jan;28(1):18-28. Review.
B lymphocytes are required for development and treatment of autoimmune diseases.
Youinou P, Jamin C, Pers JO, Berthou C, Saraux A, Renaudineau Y.
Ann N Y Acad Sci. 2005 Jun;1050:19-33. Review.
[B lymphocyte].
Hasegawa M.
Nihon Rinsho Meneki Gakkai Kaishi. 2005 Oct;28(5):300-8. Review. Japanese.
Checkpoints in lymphocyte development and autoimmune disease.
von Boehmer H, Melchers F.
Nat Immunol. 2010 Jan;11(1):14-20. Epub 2009 Dec 17. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on